Market Flash

As the global healthcare industry experiences a period of robust growth, the frequency of mergers and acquisitions (M&A) among pharmaceutical companies has been steadily increasing.

According to the recent "2023 Annual Drug Review Report" published by China's National Medical Products Administration, China has achieved significant results in the field of drug development.

Spiber, a leading innovator in synthetic biology, has recently announced a supply chain partnership with three renowned Italian textile giants - Marzotto, RDGruppoFlorence, and FilaturaPapiFabio.

In the surging global spider silk protein market, Chinese innovative companies are investing in research and production at an unprecedented pace and scale.

In recent years, Aurisco Pharmaceutical has achieved remarkable success in its focus on formulation products.

In Aurisco Pharmaceutical's carefully planned and strategic roadmap, the peptide and oligonucleotide businesses have been assigned a crucial role, viewed as the key engines driving the company's future growth.

In the recent round of centralized procurement of insulin, the market dynamics have attracted widespread attention.

In the context of intensifying global competition in the insulin market, Ganlee Pharmaceutical, a leading Chinese diabetes drug development company, is actively expanding its innovative footprint in the GLP-1 receptor agonist (GLP-1RA) field.

European Commission published an important announcement, Regulation (EU) 2024/1892, which aims to extend the approval periods for four specific active substances to ensure continued stability and food security in the agricultural sector.

Mondi, the UK-based sustainable packaging and paper company, has announced a collaboration with traceless, an advanced biomaterials engineering company, to develop a bio-recyclable packaging coating solution.

• Mondi
• traceless

Kemira is investing in the expansion of its Ferric Chloride production capacity in Tarragona, Spain, to produce a specific biogas product BDP (Biogas Digestion Product).

• Kemira

Seaweed Bath Co announced the acquisition of Andalou Naturals and Mineral Fusion from BWX.

• Seaweed Bath
• Andalou Naturals
• Mineral Fusion

On June 11, 2023, the Minister of Agriculture of Kazakhstan signed an important decree addressing issues related to sugar exports.

Vietnam Sugar and Sugar-Cane Association (VSSA) has conducted in-depth research and analysis, and believes that the current definition of sugary drinks in the Vietnamese standard (TCVN) no longer aligns with the industry's development trend.

According to the latest news from the European Food Safety Authority (EFSA), on July 5, 2024, the agency conducted a peer review of the pesticide risk assessment for the active substance lenacil (an herbicide) and published a detailed report.

European Food Safety Authority (EFSA) published its expert opinion on the safety assessment of the food enzyme triacylglycerol lipase, produced by Amano Enzyme Inc.

On July 4, 2024, the European Food Safety Authority (EFSA) published its official safety assessment report on the food enzyme bacillolysin (EC 3.4.24.28).

European Food Safety Authority (EFSA) conducted a comprehensive assessment of the safety of the β-glucosidase (EC 3.2.1.21) food enzyme and issued its scientific opinion.

Nagase (Europa) GmbH has produced the food enzyme Bacillus protease (EC 3.4.21.62) using a non-genetically modified variant of the bacterium Bacillus licheniformis, strain AP-01.

European Food Safety Authority (EFSA) issued a detailed opinion on the safety evaluation of the food enzyme α-amylase (α-amylase, also known as 4-α-D-glucan glucanohydrolase, EC 3.2.1.1).